{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:44:31Z","timestamp":1776091471342,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771449"],"award-info":[{"award-number":["81771449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China under Grant","doi-asserted-by":"publisher","award":["81801341"],"award-info":[{"award-number":["81801341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011485","name":"North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill","doi-asserted-by":"crossref","award":["2017zhyx17"],"award-info":[{"award-number":["2017zhyx17"]}],"id":[{"id":"10.13039\/100011485","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Anhui Provincial Key R&D Programme","award":["202004j07020030"],"award-info":[{"award-number":["202004j07020030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale and objective<\/jats:title>\n                <jats:p>Clozapine (CLZ) is the most effective drug for treatment-resistant schizophrenia but is associated with many side effects, including glycometabolism disorders. Immunological mechanisms may be involved in the development of clozapine side effects. Research relating the immunomodulatory effects of clozapine and its early markers to clinically relevant adverse events is needed to reduce the harmful side effects of clozapine. This study aimed to investigate the role of proinflammatory cytokines in clozapine-associated glycometabolism disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We measured the effect of a range of doses of clozapine on glycometabolism-related parameters and proinflammatory cytokines levels in mice peripheral blood. We also examined the differences between these indicators in the peripheral blood of clozapine-treated schizophrenia patients and healthy controls. Furthermore, we detected proinflammatory cytokines expression in mice pancreatic tissue.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Following clozapine administration, glucagon significantly decreased in mouse serum, and proinflammatory cytokine IL-\u03b2 levels markedly increased. Clozapine reliably increased proinflammatory cytokines (IL-1\u03b2, IL-6, and TNF-\u03b1) expression in murine pancreatic tissue. Compared with healthy controls, clozapine-treated patients\u2019 BMI, blood glucose, and proinflammatory cytokines (IL-1\u03b2, IL-6, and TNF-\u03b1) increased significantly. In clozapine-treated patients, a higher clozapine daily dosage was associated with higher levels of the proinflammatory cytokines IL-1\u03b2 and IL-6, and a significant positive correlation was observed between blood glucose levels and the proinflammatory cytokines IL-6 and TNF-\u03b1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Findings from animal experiments and clinical trials have shown clear evidence that clozapine has a regulatory effect on immune-related proinflammatory cytokines and influences glycometabolism indicators.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00213-021-05824-9","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T21:02:31Z","timestamp":1616878951000},"page":"1979-1990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?"],"prefix":"10.1007","volume":"238","author":[{"given":"Tongtong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuai","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-5249","authenticated-orcid":false,"given":"Huanzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,27]]},"reference":[{"key":"5824_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fendo.2020.00195","volume":"11","author":"S Alvarez-Herrera","year":"2020","unstructured":"Alvarez-Herrera S, Escamilla R, Medina-Contreras O, Saracco R, Flores Y, Hurtado-Alvarado G, Maldonado-Garc\u00eda JL, Becerril-Villanueva E, P\u00e9rez-S\u00e1nchez G, Pav\u00f3n L (2020) Immunoendocrine peripheral effects induced by atypical antipsychotics. Front Endocrinol (Lausanne) 11:195. https:\/\/doi.org\/10.3389\/fendo.2020.00195","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5824_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/070674370204700805","volume":"47","author":"T Baptista","year":"2002","unstructured":"Baptista T, Beaulieu S (2002) Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? Can J Psychiatr 47:742\u2013749. https:\/\/doi.org\/10.1177\/070674370204700805","journal-title":"Can J Psychiatr"},{"key":"5824_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","volume":"233","author":"D Baumeister","year":"2016","unstructured":"Baumeister D, Ciufolini S, Mondelli V (2016) Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? Psychopharmacology 233:1575\u20131589. https:\/\/doi.org\/10.1007\/s00213-015-4044-5","journal-title":"Psychopharmacology"},{"key":"5824_CR4","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s00213-016-4324-8","volume":"233","author":"L Benarroch","year":"2016","unstructured":"Benarroch L, Kowalchuk C, Wilson V, Teo C, Guenette M, Chintoh A, Nesarajah Y, Taylor V, Selby P, Fletcher P, Remington GJ, Hahn MK (2016) Atypical antipsychotics and effects on feeding: from mice to men. Psychopharmacology 233:2629\u20132653. https:\/\/doi.org\/10.1007\/s00213-016-4324-8","journal-title":"Psychopharmacology"},{"key":"5824_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1055\/s-2007-979197","volume":"32","author":"N Bergemann","year":"1999","unstructured":"Bergemann N, Ehrig C, Diebold K, Mundt C, von Einsiedel R (1999) Asymptomatic pancreatitis associated with clozapine. Pharmacopsychiatry. 32:78\u201380. https:\/\/doi.org\/10.1055\/s-2007-979197","journal-title":"Pharmacopsychiatry."},{"key":"5824_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","volume":"37","author":"W Beumer","year":"2012","unstructured":"Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA, Cohen D (2012) Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology. 37:1901\u20131911. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.04.001","journal-title":"Psychoneuroendocrinology."},{"key":"5824_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fnins.2017.00643","volume":"11","author":"J Chen","year":"2017","unstructured":"Chen J, Huang XF, Shao R, Chen C, Deng C (2017) Molecular mechanisms of antipsychotic drug-induced diabetes. Front Neurosci 11:643. https:\/\/doi.org\/10.3389\/fnins.2017.00643","journal-title":"Front Neurosci"},{"key":"5824_CR8","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.lfs.2004.12.004","volume":"76","author":"CY Cheng","year":"2005","unstructured":"Cheng CY, Hong CJ, Tsai SJ (2005) Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB\/c mice. Life Sci 76:2269\u20132273. https:\/\/doi.org\/10.1016\/j.lfs.2004.12.004","journal-title":"Life Sci"},{"key":"5824_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.pnpbp.2007.09.012","volume":"32","author":"GD Cooper","year":"2008","unstructured":"Cooper GD, Harrold JA, Halford JC, Goudie AJ (2008) Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog Neuro-Psychopharmacol Biol Psychiatry 32:428\u2013436. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.09.012","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5824_CR10","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720\u20133732. https:\/\/doi.org\/10.1182\/blood-2010-07-273417","journal-title":"Blood."},{"key":"5824_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107. https:\/\/doi.org\/10.1038\/nri2925","journal-title":"Nat Rev Immunol"},{"key":"5824_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","volume":"19","author":"MY Donath","year":"2019","unstructured":"Donath MY, Dinarello CA, Mandrup-Poulsen T (2019) Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol 19:734\u2013746. https:\/\/doi.org\/10.1038\/s41577-019-0213-9","journal-title":"Nat Rev Immunol"},{"key":"5824_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ni.3659","volume":"18","author":"E Dror","year":"2017","unstructured":"Dror E, Dalmas E, Meier DT, Wueest S, Th\u00e9venet J, Thienel C, Timper K, Nordmann TM, Traub S, Schulze F, Item F, Vallois D, Pattou F, Kerr-Conte J, Lavallard V, Berney T, Thorens B, Konrad D, B\u00f6ni-Schnetzler M, Donath MY (2017) Postprandial macrophage-derived IL-1\u03b2 stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol 18:283\u2013292. https:\/\/doi.org\/10.1038\/ni.3659","journal-title":"Nat Immunol"},{"key":"5824_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0091-3057(03)00079-0","volume":"75","author":"DS Dwyer","year":"2003","unstructured":"Dwyer DS, Donohoe D (2003) Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake. Pharmacol Biochem Behav 75:255\u2013260. https:\/\/doi.org\/10.1016\/s0091-3057(03)00079-0","journal-title":"Pharmacol Biochem Behav"},{"key":"5824_CR15","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2147\/ndt.S202159","volume":"15","author":"X Fang","year":"2019","unstructured":"Fang X, Wang Y, Chen Y, Ren J, Zhang C (2019) Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics. Neuropsychiatr Dis Treat 15:2161\u20132170. https:\/\/doi.org\/10.2147\/ndt.S202159","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5824_CR16","doi-asserted-by":"publisher","first-page":"602121","DOI":"10.3389\/fpsyt.2020.602121","volume":"11","author":"X Fang","year":"2020","unstructured":"Fang X, Yu L, Wang D, Chen Y, Wang Y, Wu Z, Liu R, Ren J, Tang W, Zhang C (2020) Association between SIRT1, cytokines, and metabolic syndrome in schizophrenia patients with olanzapine or clozapine monotherapy. Front Psychiatry 11:602121. https:\/\/doi.org\/10.3389\/fpsyt.2020.602121","journal-title":"Front Psychiatry"},{"key":"5824_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tem.2014.02.004","volume":"25","author":"MA Febbraio","year":"2014","unstructured":"Febbraio MA (2014) Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol Metab 25:312\u2013319. https:\/\/doi.org\/10.1016\/j.tem.2014.02.004","journal-title":"Trends Endocrinol Metab"},{"key":"5824_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA (2015) Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes 6:598\u2013612. https:\/\/doi.org\/10.4239\/wjd.v6.i4.598","journal-title":"World J Diabetes"},{"key":"5824_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","volume":"157","author":"DC Henderson","year":"2000","unstructured":"Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC (2000) Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 157:975\u2013981. https:\/\/doi.org\/10.1176\/appi.ajp.157.6.975","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"5824_CR20","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1055\/s-2005-858252","volume":"67","author":"C Herder","year":"2005","unstructured":"Herder C, Illig T, Rathmann W, Martin S, Haastert B, M\u00fcller-Scholze S, Holle R, Thorand B, Koenig W, Wichmann HE, Kolb H (2005) Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen. 67(Suppl 1):S115\u2013S121. https:\/\/doi.org\/10.1055\/s-2005-858252","journal-title":"Gesundheitswesen."},{"key":"5824_CR21","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","volume":"45","author":"H Himmerich","year":"2011","unstructured":"Himmerich H, Sch\u00f6nherr J, Fulda S, Sheldrick AJ, Bauer K, Sack U (2011) Impact of antipsychotics on cytokine production in-vitro. J Psychiatr Res 45:1358\u20131365. https:\/\/doi.org\/10.1016\/j.jpsychires.2011.04.009","journal-title":"J Psychiatr Res"},{"key":"5824_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s002139900351","volume":"149","author":"D Hinze-Selch","year":"2000","unstructured":"Hinze-Selch D, Deuschle M, Weber B, Heuser I, Pollm\u00e4cher T (2000) Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight. Psychopharmacology 149:163\u2013169. https:\/\/doi.org\/10.1007\/s002139900351","journal-title":"Psychopharmacology"},{"key":"5824_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","volume":"40","author":"L Hirsch","year":"2017","unstructured":"Hirsch L, Yang J, Bresee L, Jette N, Patten S, Pringsheim T (2017) Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies. Drug Saf 40:771\u2013781. https:\/\/doi.org\/10.1007\/s40264-017-0543-0","journal-title":"Drug Saf"},{"key":"5824_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20194934","volume":"20","author":"CC Hsiao","year":"2019","unstructured":"Hsiao CC, Lin CC, Hou YS, Ko JY, Wang CJ (2019) Low-energy extracorporeal shock wave ameliorates streptozotocin induced diabetes and promotes pancreatic beta cells regeneration in a rat model. Int J Mol Sci 20:20. https:\/\/doi.org\/10.3390\/ijms20194934","journal-title":"Int J Mol Sci"},{"key":"5824_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR (2010) Rethinking schizophrenia. Nature. 468:187\u2013193. https:\/\/doi.org\/10.1038\/nature09552","journal-title":"Nature."},{"key":"5824_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.schres.2018.04.022","volume":"199","author":"SV Kalmady","year":"2018","unstructured":"Kalmady SV, Shivakumar V, Jose D, Ravi V, Keshavan MS, Gangadhar BN, Venkatasubramanian G (2018) Plasma cytokines in minimally treated schizophrenia. Schizophr Res 199:292\u2013296. https:\/\/doi.org\/10.1016\/j.schres.2018.04.022","journal-title":"Schizophr Res"},{"key":"5824_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.psychres.2014.04.049","volume":"218","author":"JP Klemettil\u00e4","year":"2014","unstructured":"Klemettil\u00e4 JP, Kampman O, Sepp\u00e4l\u00e4 N, Viikki M, H\u00e4m\u00e4l\u00e4inen M, Moilanen E, Leinonen E (2014) Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine. Psychiatry Res 218:277\u2013283. https:\/\/doi.org\/10.1016\/j.psychres.2014.04.049","journal-title":"Psychiatry Res"},{"key":"5824_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.psyneuen.2008.08.016","volume":"34","author":"M Kluge","year":"2009","unstructured":"Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollm\u00e4cher T (2009) Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology. 34:118\u2013128. https:\/\/doi.org\/10.1016\/j.psyneuen.2008.08.016","journal-title":"Psychoneuroendocrinology."},{"key":"5824_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH (2015) Antipsychotic medication in schizophrenia: a review. Br Med Bull 114:169\u2013179. https:\/\/doi.org\/10.1093\/bmb\/ldv017","journal-title":"Br Med Bull"},{"key":"5824_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/jcp.0000000000000922","volume":"38","author":"J Lally","year":"2018","unstructured":"Lally J, Al Kalbani H, Krivoy A, Murphy KC, Gaughran F, MacCabe JH (2018) Hepatitis, interstitial nephritis, and pancreatitis in association with clozapine treatment: a systematic review of case series and reports. J Clin Psychopharmacol 38:520\u2013527. https:\/\/doi.org\/10.1097\/jcp.0000000000000922","journal-title":"J Clin Psychopharmacol"},{"key":"5824_CR31","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen CM, Faulenbach M, Vaag A, V\u00f8lund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517\u20131526. https:\/\/doi.org\/10.1056\/NEJMoa065213","journal-title":"N Engl J Med"},{"key":"5824_CR32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41598-018-36930-y","volume":"9","author":"H Li","year":"2019","unstructured":"Li H, Peng S, Li S, Liu S, Lv Y, Yang N, Yu L, Deng YH, Zhang Z, Fang M, Huo Y, Chen Y, Sun T, Li W (2019) Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance. Sci Rep 9:1582. https:\/\/doi.org\/10.1038\/s41598-018-36930-y","journal-title":"Sci Rep"},{"key":"5824_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1176\/appi.ajp.160.2.290","volume":"160","author":"JP Lindenmayer","year":"2003","unstructured":"Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160:290\u2013296. https:\/\/doi.org\/10.1176\/appi.ajp.160.2.290","journal-title":"Am J Psychiatry"},{"key":"5824_CR34","doi-asserted-by":"crossref","unstructured":"Liu H, Cai H, Ren Z, Zhong J, Li JJIJoP. (2015) Clozapine regulates cytokines, t cell subsets and immunoglobulins serum levels in MK-801-evoked schizophrenia rat. 11:596\u2013603.\u00a0https:\/\/www.scialert.net\/jhome.php?issn=1811-7775","DOI":"10.3923\/ijp.2015.596.603"},{"key":"5824_CR35","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1038\/s41598-017-02884-w","volume":"7","author":"X Liu","year":"2017","unstructured":"Liu X, Wu Z, Lian J, Hu CH, Huang XF, Deng C (2017) Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats. Sci Rep 7:2762. https:\/\/doi.org\/10.1038\/s41598-017-02884-w","journal-title":"Sci Rep"},{"key":"5824_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri2922","volume":"11","author":"D Mathis","year":"2011","unstructured":"Mathis D, Shoelson SE (2011) Immunometabolism: an emerging frontier. Nat Rev Immunol 11:81\u201383. https:\/\/doi.org\/10.1038\/nri2922","journal-title":"Nat Rev Immunol"},{"key":"5824_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-003-1529-4","volume":"170","author":"KI Melkersson","year":"2003","unstructured":"Melkersson KI, Dahl ML (2003) Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses. Psychopharmacology 170:157\u2013166. https:\/\/doi.org\/10.1007\/s00213-003-1529-4","journal-title":"Psychopharmacology"},{"key":"5824_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cyto.2011.09.029","volume":"57","author":"S Mirza","year":"2012","unstructured":"Mirza S, Hossain M, Mathews C, Martinez P, Pino P, Gay JL, Rentfro A, McCormick JB, Fisher-Hoch SP (2012) Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine. 57:136\u2013142. https:\/\/doi.org\/10.1016\/j.cyto.2011.09.029","journal-title":"Cytokine."},{"key":"5824_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0165-1781(97)00036-x","volume":"71","author":"P Monteleone","year":"1997","unstructured":"Monteleone P, Fabrazzo M, Tortorella A, Maj M (1997) Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res 71:11\u201317. https:\/\/doi.org\/10.1016\/s0165-1781(97)00036-x","journal-title":"Psychiatry Res"},{"key":"5824_CR40","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1248\/bpb.b18-00195","volume":"41","author":"M Nagata","year":"2018","unstructured":"Nagata M, Kimura Y, Ishiwata Y, Takahashi H, Yasuhara M (2018) Clozapine-induced acute hyperglycemia is accompanied with elevated serum concentrations of adrenaline and glucagon in rats. Biol Pharm Bull 41:1286\u20131290. https:\/\/doi.org\/10.1248\/bpb.b18-00195","journal-title":"Biol Pharm Bull"},{"issue":"Suppl 1","key":"5824_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1\u201393. https:\/\/doi.org\/10.2165\/00023210-200519001-00001","journal-title":"CNS Drugs"},{"key":"5824_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40360-017-0171-4","volume":"18","author":"T Nikoli\u0107","year":"2017","unstructured":"Nikoli\u0107 T, Petronijevi\u0107 M, Sopta J, Velimirovi\u0107 M, Stojkovi\u0107 T, Jevti\u0107 Do\u017eudi\u0107 G, Aksi\u0107 M, Radonji\u0107 NV, Petronijevi\u0107 N (2017) Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine. BMC Pharmacol Toxicol 18:65. https:\/\/doi.org\/10.1186\/s40360-017-0171-4","journal-title":"BMC Pharmacol Toxicol"},{"key":"5824_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2014.03.020","volume":"156","author":"KE O\u2019Connell","year":"2014","unstructured":"O\u2019Connell KE, Thakore J, Dev KK (2014) Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine. Schizophr Res 156:1\u20138. https:\/\/doi.org\/10.1016\/j.schres.2014.03.020","journal-title":"Schizophr Res"},{"key":"5824_CR44","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s00125-011-2088-6","volume":"54","author":"MN Pham","year":"2011","unstructured":"Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, Hunter S, Leslie RD, Schloot NC (2011) Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia. 54:1630\u20131638. https:\/\/doi.org\/10.1007\/s00125-011-2088-6","journal-title":"Diabetologia."},{"key":"5824_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama. 286:327\u2013334. https:\/\/doi.org\/10.1001\/jama.286.3.327","journal-title":"Jama."},{"key":"5824_CR46","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1038\/emm.2016.6","volume":"48","author":"PV R\u00f6der","year":"2016","unstructured":"R\u00f6der PV, Wu B, Liu Y, Han W (2016) Pancreatic regulation of glucose homeostasis. Exp Mol Med 48:e219. https:\/\/doi.org\/10.1038\/emm.2016.6","journal-title":"Exp Mol Med"},{"key":"5824_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","volume":"140","author":"R R\u00f8ge","year":"2012","unstructured":"R\u00f8ge R, M\u00f8ller BK, Andersen CR, Correll CU, Nielsen J (2012) Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? Schizophr Res 140:204\u2013213. https:\/\/doi.org\/10.1016\/j.schres.2012.06.020","journal-title":"Schizophr Res"},{"key":"5824_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/schbul\/sbn104","volume":"36","author":"YE Savoy","year":"2010","unstructured":"Savoy YE, Ashton MA, Miller MW, Nedza FM, Spracklin DK, Hawthorn MH, Rollema H, Matos FF, Hajos-Korcsok E (2010) Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation. Schizophr Bull 36:410\u2013418. https:\/\/doi.org\/10.1093\/schbul\/sbn104","journal-title":"Schizophr Bull"},{"key":"5824_CR49","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1038\/s41598-020-59701-0","volume":"10","author":"F Schulze","year":"2020","unstructured":"Schulze F, Wehner J, Kratschmar DV, Makshana V, Meier DT, H\u00e4uselmann SP, Dalmas E, Thienel C, Dror E, Wiedemann SJ, Traub S, Nordmann TM, Rachid L, De Baat A, Rohm TV, Zhao C, Odermatt A, B\u00f6ni-Schnetzler M, Donath MY (2020) Inhibition of IL-1beta improves glycaemia in a mouse model for gestational diabetes. Sci Rep 10:3035. https:\/\/doi.org\/10.1038\/s41598-020-59701-0","journal-title":"Sci Rep"},{"key":"5824_CR50","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jsps.2015.06.006","volume":"24","author":"R Shah","year":"2016","unstructured":"Shah R, Subhan F, Ali G, Ullah I, Ullah S, Shahid M, Ahmad N, Fawad K (2016) Olanzapine induced biochemical and histopathological changes after its chronic administration in rats. Saudi Pharm J 24:698\u2013704. https:\/\/doi.org\/10.1016\/j.jsps.2015.06.006","journal-title":"Saudi Pharm J"},{"key":"5824_CR51","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2174\/1570159x15666170630163616","volume":"16","author":"S Siafis","year":"2018","unstructured":"Siafis S, Tzachanis D, Samara M, Papazisis G (2018) Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr Neuropharmacol 16:1210\u20131223. https:\/\/doi.org\/10.2174\/1570159x15666170630163616","journal-title":"Curr Neuropharmacol"},{"key":"5824_CR52","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","volume":"52","author":"J Spranger","year":"2003","unstructured":"Spranger J, Kroke A, M\u00f6hlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 52:812\u2013817. https:\/\/doi.org\/10.2337\/diabetes.52.3.812","journal-title":"Diabetes."},{"key":"5824_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","volume":"33","author":"H Sugino","year":"2009","unstructured":"Sugino H, Futamura T, Mitsumoto Y, Maeda K, Marunaka Y (2009) Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuro-Psychopharmacol Biol Psychiatry 33:303\u2013307. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.12.006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5824_CR54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","volume":"74","author":"J Tiihonen","year":"2017","unstructured":"Tiihonen J, Mittendorfer-Rutz E, Majak M, Meht\u00e4l\u00e4 J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H (2017) Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia. JAMA Psychiatry 74:686\u2013693. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.1322","journal-title":"JAMA Psychiatry"},{"key":"5824_CR55","doi-asserted-by":"publisher","first-page":"e0182359","DOI":"10.1371\/journal.pone.0182359","volume":"12","author":"AL Van Dyke","year":"2017","unstructured":"Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M (2017) Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States. PLoS One 12:e0182359. https:\/\/doi.org\/10.1371\/journal.pone.0182359","journal-title":"PLoS One"},{"key":"5824_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","volume":"211","author":"H Verdoux","year":"2019","unstructured":"Verdoux H, Quiles C, de Leon J (2019) Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review. Schizophr Res 211:1\u20139. https:\/\/doi.org\/10.1016\/j.schres.2019.07.040","journal-title":"Schizophr Res"},{"key":"5824_CR57","doi-asserted-by":"publisher","first-page":"479587","DOI":"10.1155\/2014\/479587","volume":"2014","author":"CM Volpe","year":"2014","unstructured":"Volpe CM, Abreu LF, Gomes PS, Gonzaga RM, Veloso CA, Nogueira-Machado JA (2014) The production of nitric oxide, IL-6, and TNF-alpha in palmitate-stimulated PBMNCs is enhanced through hyperglycemia in diabetes. Oxidative Med Cell Longev 2014:479587\u2013479512. https:\/\/doi.org\/10.1155\/2014\/479587","journal-title":"Oxidative Med Cell Longev"},{"key":"5824_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.taap.2018.11.007","volume":"363","author":"W Wang","year":"2019","unstructured":"Wang W, Bai M, Jiang T, Li C, Li P, Zhou H, Wang Z, Li L, Jiang H (2019) Clozapine-induced reduction of l-carnitine reabsorption via inhibition\/down-regulation of renal carnitine\/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice. Toxicol Appl Pharmacol 363:47\u201356. https:\/\/doi.org\/10.1016\/j.taap.2018.11.007","journal-title":"Toxicol Appl Pharmacol"},{"key":"5824_CR59","doi-asserted-by":"publisher","unstructured":"Zhou Q, Melton DA (2018) Pancreas regeneration. Nature 557:351\u2013358. https:\/\/doi.org\/10.1038\/s41586-018-0088-0","DOI":"10.1038\/s41586-018-0088-0"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05824-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:16:08Z","timestamp":1625494568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,27]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5824"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05824-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,27]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}